ダウンロード数 : ?
言語
英語
著者
Sakurai Yuuichi Takeda Development Center Japan, Takeda Pharmaceutical Company Ltd, Osaka, Japan
Shiino Madoka Takeda Development Center Japan, Takeda Pharmaceutical Company Ltd, Osaka, Japan
Kudou Kentaro Takeda Development Center Japan, Takeda Pharmaceutical Company Ltd, Osaka, Japan
Nishimura Akira Takeda Development Center Japan, Takeda Pharmaceutical Company Ltd, Osaka, Japan
Miyagi Takuya Department of Gastroenterology and Hepatology, Yao Municipal Hospital, Yao, Japan
Iwakiri Katsuhiko Department of Gastroenterology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan
Umegaki Eiji Department of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan
Ashida Kiyoshi Department of Gastroenterology, Rakuwakai Otowa Hospital, Kyoto, Japan
主題
gastroesophageal reflux; heartburn; NERD; nonerosive gastroesophageal reflux disease; potassium-competitive acid blockers; vonoprazan
掲載誌名
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
81-82
開始ページ
1
終了ページ
7
ISSN
0011-393X
ISSN(Online)
1879-0313
発行日
2016
DOI
PubMed ID
出版者
ELSEVIER SCIENCE INC
資料タイプ
学術雑誌論文
部局
医学部
備考
This work was supported by Takeda Pharmaceutical Company Limited, manufacturer / licensee of vonoprazan. Medical writing assistance was provided by Elise Magatova, PhD, and Tania Dickson, PhD, of ProScribe - Envision Pharma Group, and was funded by Takeda Pharmaceutical Company Limited. ProScribe's services complied with international guidelines for Good Publication Practice (GPP3).